CANTABRIA LABS DIFA COOPER: THE NEW BRAND THAT CELEBRATES LIFE
A turnover of 30 million euros (+12% on 2016), 120 collaborators, 60 years of experience on the market and an Italian leadership in dermatological medical prescription: these are the numbers of Difa Cooper, a subsidiary of the Cantabria Labs group, pitted at the annual international convention of the virtuous Spanish pharmaceutical company.
The meeting, which took place in Lisbon a few days ago, was also the occasion for the launch of the new corporate image, in the presence of all the employees of the 7 branches (in addition to Italy, Spain, China, Morocco, Mexico, Portugal and Germany). The icon of the new brand (a “happy man” who raises his arms as a sign of optimism towards life) is further emphasized by the new payoff: Celebrate Life.
A natural and important evolution that the CEO of the Cantabria Labs group, Juan Matji, comments as follows: “At Cantabria Labs we wish to proudly celebrate belonging to a corporate group that always focuses on innovation and enterprise. This new identity is the result of a global growth which, from a pharmaceutical industry, leads us to become an international company specializing in dermatology and opening up to other specializations in the healthcare sector.”
“In Italy, we will experience the push towards innovation applied to medical dermatology even more intensely, which will allow us to offer unique solutions by welcoming new targets.” explains the CEO of Cantabria Labs Difa Cooper Stefano Fatelli.
Leader in dermatology in the markets of Spain, Italy and Portugal, the Cantabria Labs group, founded in 1989 and known as IFC (Industrial Farmacéutica Cantabria), has been dedicated for the past 30 years to improving the quality of life of people in 80 countries and investing 12% of turnover in R&D. And that optimism reigns in this consolidated pharmaceutical reality can be deduced from the forecasts for future development (the expansion of the market in Russia, the United States and France) and from the turnover target by 2022: reaching the threshold of 300 million against 150 current.
